Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study To Assess Healing of Repaired Tibias with Sclerostin Antibody (STARTT)
2008-008392-34Phase 2Completed
- Sponsor
- Amgen
- Start
- Jun 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tibia fracture comparing AMG 785 with Placebo (2 arms). Primary endpoint: Time to radiographic healing. Started Jun 2009; status: completed.
02
Drugs
romosozumab
03
Conditions
tibia fracture
Beyond the preview
Go deeper on 2008-008392-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008392-34.